Pfizer Inc. (PFE) said the High Court in Dublin has ruled that the patent covering atorvastatin, the active ingredient in Lipitor, would be infringed by a competitor product from Ranbaxy.
The decision, which is subject to a possible appeal, would prevent Ranbaxy from launching a copycat drug before November 2011.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment